Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns. 2014; 40:(4)583-588

Barikbin B, Akbari Z, Yousefi M, Dowlati Y. Blunt blade subcision: an evolution in the treatment of atrophic acne scars. Dermatol Surg. 2017; 43:S57-S63

Beer K. A single-center, open-label study on the use of injectable poly-l-lactic acid for the treatment of moderate to severe scarring from acne or varicella: injectable plla for acne scarS. Dermatol Surg. 2007; 33:S159-S167

Cho SB, Park CO, Chung WG Histometric and histochemical analysis of the effect of trichloroacetic acid concentration in the chemical reconstruction of skin scars method. Dermatol Surg. 2006; 32:(10)1231-1236

Coleman SR. Structural fat grafting: more than a permanent filler. Plastic Reconstruct Surg. 2006; 118:108S-120S

Fabbrocini G, Annunziata MC, D'Arco V Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010; 2010:1-13

Forbat E, Ali FR, Al-Niaimi F. The role of fillers in the management of acne scars. Clin Experiment Dermatol. 2017; 42:(4)374-380

Fulton J, Caperton C, Weinkle S, Dewandre L. Filler injections with the blunt-tip microcannula. J Drugs Dermatol. 2012; 11:(9)1098-1103

Gerald O'Daniel T. Multimodal management of atrophic acne scarring in the aging face. Aesthet Plast Surg. 2011; 35:(6)1143-1150

Gheisari M, Iranmanesh B, Saghi B. Blunt cannula subcision is more effective than Nokor needle subcision for acne scars treatment. J Cosmet Dermatol. 2018; 9

Gozali MV, Zhou B. Effective treatments of atrophic acne scars. J Clin Aesthet Dermatol. 2015; 8:(5)33-40

Gu Z, Li Y, Li H. Use of condensed nanofat combined with fat grafts to treat atrophic scars. JAMA Facial Plast Surg. 2018; 20:(2)

Hexsel D, Soirefmann M, Donida Porto M Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012; 38:(2 Part 1)207-214

Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994; 19:(4)303-308

van Loghem JAJ, Humzah D, Kerscher M. Cannula versus sharp needle for placement of soft tissue fillers: an observational cadaver study. Aesthet Surg J. 2016;

Negenborn VL, Groen J-W, Smit JM The use of autologous fat grafting for treatment of scar tissue and scar-related conditions: a systematic review. Plast Surg Nurs. 2016; 36:(3)131-143

Newberry C, Thomas J, Cerrati E. Facial scar improvement procedures. Facial Plast Surg. 2018; 34:(05)448-457

Nilforoshzadeh M, Lotfi E, Nickkholgh E Can subcision with the cannula be an acceptable alternative method in treatment of acne scars?. Med Arch. 2015; 69:(6)

O'Daniel TG. Multimodal management of atrophic acne scarring in the aging face. Aesthetic Plast Surg. 2011; 35:(6)1143-1150

Pallua N, Baroncini A, Alharbi Z, Stromps JP. Improvement of facial scar appearance and microcirculation by autologous lipofilling. J Plast Reconstr Aesthet Surg. 2014; 67:(8)1033-1037

Pavicic T, Frank K, Erlbacher K Precision in dermal filling: a comparison between needle and cannula when using soft tissue fillers. J Drugs Dermatol. 2017; 16:(9)866-872

Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 1997; 38:(3)115-123

Tansatit T, Apinuntrum P, Phetudom T. A dark side of the cannula injections: how arterial wall perforations and emboli occur. Aesthet Plast Surg. 2017; 41:(1)221-227

Tanzi E, Wanitphakdeedecha R, Alster T. Fraxel laser indications and long-term follow-up. Aesthet Surg J. 2008; 28:(6)675-678

Tanzi EL, Alster TS. Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study. Dermatol Surg. 2004; 30:(2 Pt 1)152-157

Tebble NJ, Thomas DW, Price P. Anxiety and self-consciousness in patients with minor facial lacerations. J Adv Nurs. 2004; 47:(4)417-426

Tenna S, Cogliandro A, Barone M Comparative study using autologous fat grafts plus platelet-rich plasma with or without fractional CO2 laser resurfacing in treatment of acne scars: analysis of outcomes and satisfaction with FACE-Q. Aesthet Plast Surg. 2017; 41:(3)661-666–3

Yug A, Lane JE, Howard MS, Kent DE. Histologic study of depressed acne scars treated with serial high-concentration (95%) trichloroacetic acid. Dermatol Surg. 2006; 32:(8)985-990

The use of the Sterimedix GTI Cannula® (Amar) in the management of facial scars and contour defects

02 February 2019
Volume 8 · Issue 1


Facial scars are common, and patients are requesting more interventions to improve the appearance of their scars and improve any contour deformity associated with the scars. Various treatment modalities have been described to improve the appearance of the scars. The Sterimedix GTI cannula® (Amar), designed by a leading plastic surgeon in the field of fat transfer for restoration of facial volume and rejuvenation, has recently been introduced to the market. Excellent patient satisfaction following the procedure and ease for the operator were achieved in undertaking the process of subcision and fat/filler transfer for volume restoration.

Facial scarring, whether it is caused by trauma, surgery or acne, can lead to considerable psychological sequelae to patients. The size of the scar, as well as the cause of it, have been shown to lead to increased levels of anxiety and self-consciousness (Tebble et al, 2004). In the modern age of social media, patients are more aware of the presence of any facial scars and irregularities, and often seek treatment to improve the appearance and quality of the scars. World-wide, acne has been estimated to affect up to 90% of adolescents (Stathakis et al, 1997), and in specialist acne clinics, some degree of acne scars have been identified in more than 95% of patients (Layton et al, 1994).

Scarring is a physiological process and any injury to the deeper reticular layer of the dermis results in the formation of scars. These can be broadly categorised into hypertrophic scars, keloid scars and atrophic scars (Gu et al, 2018), with abnormal accumulation of extracellular matrix, mainly abnormal collagen, being the main cause of keloid and hypertrophic scars (Gu et al, 2018). An atrophic scar is sunken, pigmented or hypopigmented, and is often associated with facial acne (Gozali and Zhou, 2015). The inflammation that is associated with moderate to severe acne leads to dermal collagen and fat loss, resulting in the appearance of an atrophic scar (Fabbrocini et al, 2010). Histologically, the loss of collagen, elastin and dermal fat results in the downward pull of the epidermis, creating the sunken appearance of the scar (Yug et al, 2006).

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month